New Arrival
Metabolic Research
Cagrilintide (10mg)
SKU: PEP-039-10MG
In Stock
Next business day dispatch cutoffNext business day dispatch cutoff16:03:46
$199.99
$229.99Save $30.00 (13%)
CoA purity: 99.892%
Long-Acting Amylin Analog (Larger Research Vial)
Cagrilintide (10mg) will be supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.
Cagrilintide is a long-acting analog of amylin — a pancreatic hormone co-secreted with insulin that contributes to satiety, gastric emptying, and post-meal glucose control. Native amylin is cleared within minutes; Cagrilintide is engineered for once-weekly research dosing and is one of the most-studied amylin-class compounds in current metabolic research.
The 10mg format doubles the 5mg vial and suits longer protocols and combination studies — particularly CagriSema-style work pairing Cagrilintide with a GLP-1 agonist, where the amylin pathway adds a second, independent satiety signal on top of the incretin mechanism.
Key Research Areas
- Appetite & Satiety — Amylin pathway signalling for reduced food intake
- Body Weight Reduction — Studied as monotherapy and in combination with GLP-1 agonists
- CagriSema Research — Cagrilintide + Semaglutide is one of the most-watched compound combinations in Phase 3 weight-management trials
- Glycaemic Control — Studied for post-meal glucose modulation via slowed gastric emptying
- Extended Protocols — Larger vial for multi-week combination studies without re-ordering
Supplied as lyophilized powder, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.
⚠ For in-vitro research and laboratory use only. Not for human consumption.
Product Specifications
| Compound | Cagrilintide (10mg) |
| Category | Metabolic Research |
| Purity | 99.892% (CoA Reported) |
| Form | Lyophilised Powder |
| Storage (Lyophilised) | -20 °C — protect from light & moisture |
| Storage (Reconstituted) | 2–8 °C — use within 8–12 weeks |
| Reconstitution | Bacteriostatic water (recommended) |
⚠ For in-vitro research and laboratory use only. Not intended for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.
Purchase Other Quantities
Cagrilintide is also available in other vial sizes. Compare the current formats below and jump straight to the quantity that fits your protocol.
Frequently Bought Together
Frequently Asked Questions
What is Cagrilintide?
Cagrilintide is a long-acting amylin analog — a synthetic version of a natural pancreatic hormone called amylin, engineered to last much longer in the body. Amylin is co-released with insulin after eating and contributes to feelings of fullness, slows how quickly your stomach empties, and helps control post-meal blood sugar. Native amylin is broken down within minutes, which is why Cagrilintide was engineered — a stable, once-weekly form that allows the same biological effects to be studied over longer time courses.
Why choose the 10mg vial over the 5mg?
The 10mg vial is the same compound at double the capacity. It suits longer research protocols and combination studies where a single vial needs to cover several weeks, and it brings the per-milligram cost down compared with the 5mg format. If you're running a short first-pass comparison, the 5mg vial is the more economical starting point.
How is Cagrilintide different from Semaglutide and Tirzepatide?
Semaglutide and Tirzepatide work through the incretin pathway — GLP-1 (and GIP, in Tirzepatide's case). Cagrilintide works through a completely separate pathway: amylin. Where GLP-1 and GIP agonists reduce appetite and improve glucose control through one mechanism, Cagrilintide adds an entirely different satiety signal on top. This is why the combination of Cagrilintide + Semaglutide (CagriSema) is being studied so intensely — it stacks two independent appetite-control mechanisms rather than amplifying one.
What is CagriSema?
CagriSema is the combination of Cagrilintide and Semaglutide — currently one of the most-watched compound combinations in Phase 3 weight management research. Cagrilintide contributes an amylin-pathway satiety signal; Semaglutide contributes the GLP-1 incretin signal. Together, they produce additive appetite suppression that early trial data suggests rivals the highest-performing tri-agonist compounds.
How do you reconstitute Cagrilintide?
Cagrilintide is supplied as a lyophilized powder and should be reconstituted with bacteriostatic water (BAC water) immediately before use. Inject the BAC water slowly into the vial, directing the stream down the inside wall. Gently swirl to dissolve — do not shake. Once reconstituted, store at 2–8°C and use within 8–12 weeks. For a full step-by-step walkthrough, see our complete peptide reconstitution guide.
How should Cagrilintide be stored?
Store lyophilized Cagrilintide vials at -20°C, away from light and moisture. After reconstitution with BAC water, refrigerate at 2–8°C and use within 8–12 weeks. Do not freeze the reconstituted solution.
Where to buy Cagrilintide 10mg in Australia?
Cagrilintide (10mg) will be available through Aussie Peptides with fast domestic shipping to all Australian states and territories. Every vial is dispatched from within Australia, reducing delays linked to international freight and customs processing. Batch-specific Certificate of Analysis access will be available in our CoA library.
What is the availability and cost of Cagrilintide 10mg?
Cagrilintide (10mg) is currently in stock at Aussie Peptides and available for domestic dispatch across Australia. Cagrilintide (10mg) is priced at $199.99 per vial at Aussie Peptides. All orders ship domestically within Australia, and batch CoAs are available in our CoA library.